Cited by 191BRCA gene mutations in cancerMultiple and Secondary Primary CancersBreast Lesions and Carcinomas

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2

Open access

Malone, Kathleen E., Begg, Colin B., Haile, Robert W., Borg, Ake, Concannon, Patrick, Tellhed, Lina, Xue, Shanyan, Teraoka, Sharon, Bernstein, Leslie, Capanu, Marinela, Reiner, Anne S., Riedel, Elyn R., Thomas, Duncan C., Mellemkjær, Lene, Lynch, Charles F., Boice, John D., Anton-Culver, Hoda, Bernstein, Jonine L.·2010·Journal of Clinical Oncology

DOI 10.1200/jco.2009.24.2495PMC PMC2881721

Open this paper in CoChat — free account Open PDF

Abstract

Purpose: Women with breast cancer diagnosed early in life comprise a substantial portion of those tested for BRCA1/BRCA2 mutations; however, little information is available on the subsequent risks of contralateral breast cancer in mutation carriers. This study assessed the risk of subsequent contralateral breast cancer associated with carrying a BRCA1 or BRCA2 mutation. Patients and Methods: In this nested case-control study, patients with contralateral breast cancer diagnosed 1 year or more after a first primary breast cancer (n = 705) and controls with unilateral breast cancer (n = 1,398) were ascertained from an underlying population-based cohort of 52,536 women diagnosed with a first invasive breast cancer before age 55 years. Interviews and medical record reviews were used to collect risk factor and treatment histories. All women were tested for BRCA1/BRCA2 mutations. Relative (rate ratios) and absolute (5- and 10-year cumulative) risks of developing contralateral breast cancer following a first invasive breast cancer were computed. Results: Compared with noncarriers, BRCA1 and BRCA2 mutation carriers had 4.5-fold (95% CI, 2.8- to 7.1-fold) and 3.4-fold (95% CI, 2.0- to 5.8-fold) increased risks of contralateral breast cancer, respectively. The relative risk of contralateral breast cancer for BRCA1 mutation carriers increased as age of first diagnosis decreased. Age-specific cumulative risks are provided for clinical guidance. Conclusion: The risks of subsequent contralateral breast cancer are substantial for women who carry a BRCA1/BRCA2 mutation. These findings have important clinical relevance regarding the assessment of BRCA1/BRCA2 status in patients with breast cancer and the counseling and clinical management of patients found to carry a mutation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1200/jco.2009.24.2495

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citation
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
Struewing, J., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,399
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D., Evans, C., Deacon, J., & Stratton, M. R. (1999) · Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 909
Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, Canada
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B. P., Bradley, L., Fan, I., Tang, J., Li, S., Zhang, S., Shaw, P. A., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj465 · Cited by 678
Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Metcalfe, K. A., Lynch, H. T., Ghadirian, P., Tung, N., Olivotto, I. A., Warner, E., Olopade, O. I., Eisen, A. F., Weber, B., McLennan, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.033 · Cited by 620
Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases
Anglian Breast Cancer Study Group (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 602
Unusual case of Smith‐Lemli‐Opitz syndrome “type II”
Seller, M. J., Russell, J., & Tint, G. S. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560305 · Cited by 584
New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000.
Curtis, R. E., Freedman, D. M., Ron, E., Ries, L. A. G., Hacker, D. G., Edwards, B. K., Tucker, M., & Fraumeni, J. F. (2006) · Cited by 527
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
Verhoog, L., Brekelmans, C., Seynaeve, C., van den Bosch, L., Dahmen, G., van Geel, A., Tilanus-Linthorst, M., Bartels, C., Wagner, A., van den Ouweland, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07065-7 · Cited by 452

Show all 36 references

Research works printed but not linked: 3

Chen Y, 1999, Cancer Epidemiol Biomarkers Prev, 8, 855
Foulkes WD, 1997, Clin Cancer Res, 3, 2465
Verhoog LC, 2000, J Clin Oncol, 18, 119S

Sorted by citations

Items 101–191 of 191

Disparities in BRCA counseling across providers in a diverse population of young breast cancer survivors
Reid, S., Cragun, D. L., Tezak, A. L., Weidner, A. E., Moore, J., Mayer, I. A., Shu, X., Ye, F., Fan, R., Vadaparampil, S. T., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0762-0 · Cited by 13
Oncology Health Professionals‘ Attitudes Toward Treatment-Focused Genetic Testing for Women Newly Diagnosed with Breast Cancer
Burcher, S., Meiser, B., Mitchell, G., Saunders, C. M., Rahman, B., Tucker, K., Barlow-Stewart, K. K., Watts, K., Gleeson, M., & Kirk, J. (2013) · Personalized Medicine · doi:10.2217/pme.13.45 · Cited by 13
Local staging of ipsilateral breast tumor recurrence: mammography, ultrasound, or MRI?
Walstra, C. J. E. F., Schipper, R., Winter-Warnars, G. A. O., Loo, C. E., Voogd, A. C., Peeters, M.-J. T. F. D. V., Nieuwenhuijzen, G. A. P., & Beets‐Tan, R. G. H. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05850-9 · Cited by 11
Incidence of contralateral and ipsilateral breast cancers and prognosis in BRCA1/2 pathogenic variant carriers based on the Japanese HBOC Consortium registration
Yoshimura, A., Yokoyama, S., Iwata, H., Takaiso, N., Nomizu, T., Arai, M., & Nakamura, S. (2020) · Journal of Human Genetics · doi:10.1038/s10038-020-00850-5 · Cited by 11
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study
Cheng, H.-F., Tsai, Y., Liu, C., Hsu, C., Lien, P., Lin, Y., Chao, T., Lai, J., Feng, C.-J., Chen, Y.-J., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01751-z · Cited by 10
Prevalence of Germline Pathogenic and Likely Pathogenic Variants in Patients With Second Breast Cancers
K, K. A. Y., Clifford, J., Li, S., LaDuca, H., Hulick, P. J., Gutierrez, S., & Black, M. H. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa094 · Cited by 10
Estrogen withdrawal, increased breast cancer risk and the KRAS-variant
McVeigh, T. P., Jung, S.-Y., Kerin, M. J., Salzman, D. W., Nallur, S. V., Nemec, A. A., Dookwah, M., Sadofsky, J., Paranjape, T., Kelly, O., et al. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1041694 · Cited by 10
Management of Genetic Syndromes Predisposing to Gynecologic Cancers
Miesfeldt, S., Lamb, A. E., & Duarte, C. W. (2013) · Current Treatment Options in Oncology · doi:10.1007/s11864-012-0215-3 · Cited by 10
Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors
Reblin, M., Kasting, M. L., Nam, K., Scherr, C. L., Kim, J., Thapa, R., Meade, C. D., Lee, M. C., Pal, T., Quinn, G. P., et al. (2018) · The Breast Journal · doi:10.1111/tbj.13165 · Cited by 9
Comparison of Survival Outcomes in Young Patients With Breast Cancer Receiving Contralateral Prophylactic Mastectomy Versus Unilateral Mastectomy
Huang, H., Wei, T., Zhang, A., Zhang, H., Kong, L., Li, Y., & Li, F. (2023) · Clinical Breast Cancer · doi:10.1016/j.clbc.2023.07.010 · Cited by 8
Management of the asymptomatic BRCA mutation carrier
Teller, P., & Munn, R. K. (2010) · The Application of Clinical Genetics · doi:10.2147/tacg.s8882 · Cited by 8
Risk of Asynchronous Contralateral Breast Cancer in Noncarriers of BRCA1 and BRCA2 Mutations With a Family History of Breast Cancer: A Report From the Women's Environmental Cancer and Radiation Epidemiology Study
Day, S., & Bevers, T. B. (2013) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2013.07.020 · Cited by 8
Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer
Watt, G. P., Reiner, A. S., Smith, S. A., Stram, D. O., Capanu, M., Malone, K. E., Lynch, C. F., John, E. M., Knight, J. A., Mellemkjær, L., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.12259 · Cited by 8
Self-citation
Breast Cancer Susceptibility Gene Sequence Variations and Development of Contralateral Breast Cancer
Reiner, A. S., Watt, G. P., Malone, K. E., Lynch, C. F., John, E. M., Knight, J. A., Woods, M., Liang, X., Tischkowitz, M. D., Conti, D. V., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.52158 · Cited by 7
Self-citation
Familiärer Brustkrebs – empirische Erkrankungsrisiken und Risikoberechnungsmodelle
Engel, C., Zachariae, S., & Fischer, C. (2015) · Medizinische Genetik · doi:10.1007/s11825-015-0043-5 · Cited by 8
Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.
Pellegrino, B., Bella, M., Michiara, M., Zanelli, P., Naldi, N., Porzio, R., Bortesi, B., Boggiani, D., Zanoni, D., Camisa, R., et al. (2016) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 7
Risk of Ipsilateral and Contralateral Cancer in BRCA Mutation Carriers with Breast Cancer
Green, L., & Meric‐Bernstam, F. (2011) · Current Breast Cancer Reports · doi:10.1007/s12609-011-0047-3 · Cited by 7
Germline BRCA Mutation and Clinical Outcomes in Breast Cancer Patients Focusing on Survival and Failure Patterns: A Long-Term Follow-Up Study of Koreans
Kim, H., Choi, D. H., & Park, W. (2020) · Medicina · doi:10.3390/medicina56100514 · Cited by 5
Addressing disparities in the uptake of genetic counseling and testing in African American women; rationale, design and methods
Sheppard, V. B., Sutton, A. L., Hurtado‐de‐Mendoza, A., Tariq, F., Perera, R. A., Quillin, J. M., Jeudy, M., Gómez‐Trillos, S., & Schwartz, M. D. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107210 · Cited by 6
A genome-wide association study of contralateral breast cancer in the Women’s Environmental Cancer and Radiation Epidemiology Study
Sun, X., Reiner, A. S., Tran, A. P., Watt, G. P., Oh, J. H., Mellemkjær, L., Lynch, C. F., Knight, J. A., John, E. M., Malone, K. E., et al. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01765-1 · Cited by 6
Self-citation
Analiza Wybranych Czynników Ryzyka Raka Piersi – Przegląd Piśmiennictwa = Analysis Of The Selected Risk Factors For Breast Cancer – Literature Review
Sowa, M., Smuczyński, W., Tarkowski, M., Wójcik, K., & Kochański, B. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.5281/zenodo.16868 · Cited by 6
Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study
Maksimenko, J., Rodrigues, P. P., Nakazawa-Miklaševiča, M., Pinto, D., Miklaševičs, E., Trofimovičs, G., Gardovskis, J., Cardoso, F., & Cardoso, M. J. (2022) · JMIR Formative Research · doi:10.2196/37144 · Cited by 6
Chinese American and Non-Hispanic White Breast Cancer Patients’ Knowledge and Use of BRCA Testing
Wang, H., Chen, L., Hsiao, H., Hsiao, S. C., Tian, H., Chang, E., Assoumou, B. O. M. T., & Wang, J. H.-Y. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043384 · Cited by 6
Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer
Mainor, C. B., & Isaacs, C. J. (2020) · Current Breast Cancer Reports · doi:10.1007/s12609-019-00350-2 · Cited by 6
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)
Hendricks, L. A. J., Verbeek, K. C. J., Schuurs-Hoeijmakers, J. H. M., de Jong, M. M., Links, T. P., Brems, H., Aerden, M., Brunet, J., Lleuger-Pujol, R., Hüneburg, R., et al. (2025) · Genetics in Medicine · doi:10.1016/j.gim.2025.101467 · Cited by 5
Risk factors for second primary breast cancer by laterality, age, and race and ethnicity
John, E. M., Koo, J., Ingles, S. A., Keegan, T. H. M., Gomez, S. L., Haiman, C. A., Kurian, A. W., Kwan, M. L., Neuhausen, S. L., Shariff‐Marco, S., et al. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae254 · Cited by 5
A Retrospective Analysis of the Relationship Between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan
Inuzuka, M., Watanabe, C., Yokoyama, S., Kuwayama, T., Akashi‐Tanaka, S., Arai, M., Nakamura, S., Nakamura, S., Enomoto, T., Nomizu, T., et al. (2020) · Clinical Breast Cancer · doi:10.1016/j.clbc.2020.08.004 · Cited by 5
Strategies to enhance identification of hereditary breast cancer gene carriers
Reid, S., Spalluto, L. B., & Pal, T. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1816829 · Cited by 5
Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
Mitchell, R. L., Buckingham, L. E., Cobleigh, M., Rotmensch, J., Burgess, K. R., & Usha, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195497 · Cited by 6
Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testing
Cruz, J. D. L., André, F., Harrell, R. K., Bassett, R. L., Arun, B., Mathieu, M., Delaloge, S., & Gilcrease, M. Z. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.02.002 · Cited by 5
Molecular Subtypes and Ki-67 index in Breast Carcinoma with Special Emphasis on Triple Negative Breast Cancer. A 3-year Study in a Tertiary Care Center
Pai, S. G., & Murthy, S. V. (2023) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-023-01773-1 · Cited by 4
Epidemiology, Risk Factors, and Prevention
Bayraktar, S., & Arun, B. (2019) · Springer eBooks · doi:10.1007/978-3-030-04606-4_4 · Cited by 4
Invasive Lobular Carcinoma of the Breast
Philippidou, M., & Pinder, S. E. (2012) · Surgical pathology clinics · doi:10.1016/j.path.2012.06.006 · Cited by 4
Disparities in Hereditary Genetic Testing in Patients with Triple Negative Breast Cancer
Gupta, S., Jones, J. E., & Smith-Graziani, D. J. (2024) · Clinical Breast Cancer · doi:10.1016/j.clbc.2024.09.018 · Cited by 3
Impact of germline BRCA1/2 mutations on response to neoadjuvant systemic therapy and prognosis in breast cancer: a propensity score matched cohort study
Kim, H., Chun, J. W., Hwang, J., Yun, S. G., Kim, J., Jung, S. P., Moon, H., Lee, E.-S., & Han, W. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02041-6 · Cited by 4
Breast Cancer Genetics
O’Donnell, M., Axilbund, J. E., & Euhus, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00017-9 · Cited by 5
Cáncer de mama contralateral y recurrencia en portadoras BRCA1/2 y no portadoras con alto riesgo de cáncer de mama hereditario tras mastectomía bilateral
Cabañuz, M. A., Bretón, M. D., Ezquerro, J. C., del Amo, M. D. A., & Sánchez, A. T. G. (2020) · Cirugía Española · doi:10.1016/j.ciresp.2020.04.008 · Cited by 3
Using an Anthropological Lens to Explore Motivators and Challenges for Follow-up Care Decision Making among Female BRCA1/2 Carriers at Risk for Inherited Cancer
Tezak, A. L., Weidner, A. E., Clouse, K., Pal, T., & Cragun, D. L. (2021) · Human Organization · doi:10.17730/1938-3525-80.3.203 · Cited by 3
Double Trouble: Contralateral Breast Cancer Risk Management in the Modern Era
Cheung, K. J., & Davidson, N. E. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy203 · Cited by 3
Rethinking contralateral breast cancer: latest insights on risk, prevention, and outcomes
Hosseini, M. (2025) · Clinical Cancer Bulletin · doi:10.1007/s44272-025-00030-6 · Cited by 2
Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy
Cabañuz, M. A., Bretón, M. D., Ezquerro, J. C., del Amo, M. D. A., & Sánchez, A. T. G. (2020) · Cirugía Española (English Edition) · doi:10.1016/j.cireng.2020.11.009 · Cited by 2
Multifocality, Multicentricity, and Bilaterality of Breast Cancer
Ilić, I. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96489 · Cited by 2
Technical and Analytical Approach for Breast Reconstruction With IMAP Propeller Flap
Spaggiari, A., Morrison, W. A., Marra, C., Lusetti, I. L., Fiocchi, F., Pinelli, M., & Santis, G. D. (2024) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000006353 · Cited by 1
Factors influencing uptake of BRCA1/2 testing and contralateral prophylactic mastectomy among Chinese breast cancer patients
Xue, Y., Wu, M., Liu, L., & Zhang, C. (2025) · Medicine · doi:10.1097/md.0000000000046604 · Cited by 1
Subsequent Primary Neoplasms and Mortality Among Survivors of Childhood Cancer in Alberta, Canada
Tam, K. W., Pitt, T. M., Reynolds, K. A., Spavor, M., Truong, T. H., Giles, J., Guilcher, G. M. T., Logie, N., Rahamatullah, I., Schulte, F., et al. (2026) · Cancers · doi:10.3390/cancers18040694 · Cited by 1
Welche Einflüsse bestimmen die Entscheidung zur prophylaktischen kontralateralen Mastektomie bei Mammakarzinom-Patientinnen?
Groß, M. W., & Zimmermann, F. B. (2012) · Strahlentherapie und Onkologie · doi:10.1007/s00066-011-0013-z · Cited by 1
Prophylactic Mastectomy and Risk-Reducing Salpingo-oophorectomy in BRCA1/2 Mutation Carriers
Maxwell, K. N., & Domchek, S. M. (2012) · Current Breast Cancer Reports · doi:10.1007/s12609-012-0086-4 · Cited by 1
Epidemiology, Risk Factors, and Prevention
Bayraktar, S., & Arun, B. (2015) · Springer eBooks · doi:10.1007/978-3-319-22843-3_4 · Cited by 2
Analysis of bilateral breast carcinomas
Pasetto, C. V., Batista, B. R., Budel, L. R., Andreoli, M. D. N., & Budel, V. M. (2021) · Mastology · doi:10.29289/2594539420200026 · Cited by 1
The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women
Larionov, A. A., Fewings, E., Redman, J., Goldgraben, M. A., Clark, G. R., Boice, J. D., CONCANNON, P. J., Bernstein, J. L., Conti, D. V., the WECARE Study Collaborative Group, et al. (2023) · Cancers · doi:10.3390/cancers15020415 · Cited by 1
Self-citation
High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old
van den Bruele, A. B., Ren, Y., Thomas, S. M., Ntowe, K. W., Rosenberger, L. H., Menendez, C. S., Grimm, L. J., Chiba, A., & Plichta, J. K. (2025) · Breast Cancer Research and Treatment · doi:10.1007/s10549-025-07657-y · Cited by 1
BRCA1 and BRCA2 Testing in Inherited Breast Cancer
Bowles, K. R., & Rosenthal, E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8127-0_10 · Cited by 1
Bilateral Breast Cancer
Barrio, A. V., & Cody, H. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00075-1 · Cited by 1
Clinical Genetics for the Gynecologist
Grignol, V. P., & Agnese, D. M. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7641-6_19 · Cited by 1
Knowledge, Attitudes, and Utilization of BRCA Testing Among Obstetricians and Gynecologists
Nassef, S. A. (2012) · Digital Commons-TMC (Texas Medical Center)
Predictors of Contralateral Breast Cancer in BRCA Negative Women
Simmons, A. (2012) · Digital Commons-TMC (Texas Medical Center)
Prophylaktische kontralaterale Mastektomie
Grischke, E. ‐. (2013) · Der Onkologe · doi:10.1007/s00761-013-2514-0
Managing BRCA Mutation Carriers in China: Reply
Kwong, A., & Ng, E. K. O. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0847-z
A population perspective to mitigating risk for second primary breast cancer
Lowery, J. T., & Risendal, B. (2013) · Breast Cancer Management · doi:10.2217/bmt.13.6
Management of women with BRCA1 / 2 mutation-associated breast cancer
Bayraktar, S., & Glück, S. (2012) · Breast Cancer Management · doi:10.2217/bmt.12.22
Estudo de moléculas de adesão no câncer de mama bilateral
Iyeyasu, H. (2011) · doi:10.11606/t.5.2011.tde-18022011-144806
Caracterización citogenética y molecular de un grupo de pacientes con cáncer de mama
Rincón, C., & Duley, Y. (2015)
Les défis de l’oncogénétique et ses applications médicales : nouvelles problématiques psycho-oncologiques ? Le modèle des prédispositions génétiques au cancer du sein et de l’ovaire
Noguès, C. (2015) · Psycho-Oncologie · doi:10.1007/s11839-015-0549-8
À propos d'une série rétrospective de cancers du sein diagnostiqués auprès de patientes présentant une mutation constitutionnelle des gènes BRCA1 ou BRCA2: traitement et suivi à long terme
Artiguenave, M. (2015) · HAL
Prophylaktische kontralaterale Mastektomie immer häufiger
Gross, M. W., & Zimmermann, F. B. (2012) · Info Onkologie · doi:10.1007/s15004-012-0258-4
Cirugía profiláctica en síndrome de cáncer hereditario de mama
Ismael Vial, L., Rosario, R.-E. M. ª., Felipe Pizarro, C., Vicente Rojas, O., & Gabriel Vial, L. (2016) · Revista de Cirugía · doi:10.1016/j.rchic.2016.06.005
Risk-Reducing Surgery for Breast Cancer Patients with BRCA Mutations
Kim, E., Kim, S., & Noh, D. (2016) · Springer eBooks · doi:10.1007/978-4-431-55552-0_1
early s tage Triple- n egative Breast cancer: Imaging and Clinical-Pathologic Factors Associated
Bae, M. S., Moon, H., Han, W., Noh, D., Ryu, H. S., Cho, N., & Moon, W. K. (2016)
Medical Management of Breast Cancer in BRCA Mutation Carriers
Bayraktar, S., & Arun, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-59198-8_8
Surgical Management of Breast Cancer in BRCA Mutation Carriers
Cronin, P. A., & Cody, H. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-59198-8_7
Utility of Regular Radiological Follow-up on Early Detection of Contralateral Malignancy and Long-term Outcomes in Metachronous Bilateral Breast Cancer Patients
Kim, H. S., & Kang, S. H. (2017) · Kosin Medical Journal · doi:10.7180/kmj.2017.32.1.72
Special Issues in Young Women with Triple-Negative Breast Cancer
Duma, N., O'Sullivan, C. C., Ruddy, K. J., & Leal, A. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-69980-6_10
Risk and Prevention for Highly Penetrant Genes
Chitalia, A., Khoury, K. E., & Isaacs, C. J. (2018) · Current Breast Cancer Reports · doi:10.1007/s12609-018-0282-y
Prédisposition génétique au cancer du sein
Noguès, C. (2016) · Elsevier eBooks · doi:10.1016/b978-2-294-74449-5.00002-2
遺伝性・家族性乳がん診療のコンセンサス −多施設アンケート結果から−
杉江, 知., 京都乳癌コンセンサス会議, 戸井, 雅., 山内, 智., 石黒, 洋., 三上, 芳., 岡村, 隆., 加藤, 大., 山内, 清., & 稲本, 俊. (2012) · doi:10.18976/jsft.12.2_45
Busting the Contralateral Prophylactic Mastectomy Myth: Incidence of Follow-up Imaging and Biopsy After Risk-Reductive Breast Surgery
DeBiase, S. R., Sun, W., Boulware, D. C., Laronga, C., & Lee, M. C. (2019) · Current Breast Cancer Reports · doi:10.1007/s12609-019-00338-y
Bilateral prophylactic mastectomy as an option for prevention of contralateral breast cancer
Pominchuk, D. V., & Shevchuk, T. S. (2020) · Reproductive Endocrinology · doi:10.18370/2309-4117.2020.55.72-78
Bilateral Synchronous and Metachronous Breast Cancer: Features of Topography, Etiology, Pathogenesis, Risk Factors, Diagnosis and Prognosis
Volos, L. I., Масна, З. З., & Vasyliv, M. A. L. (2022) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs07.04.006
Genetics and Prevention
Brehm, J. L., & Wham, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93249-3.00015-1
Locally Advanced Breast Cancer
Lopez, A., & Mancinelli, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-78244-2_10
The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancer
Loža, P., Irmejs, A., Daneberga, Z., Maksimenko, J., Trofimovičs, G., Subatniece, S., Gronwald, J., Lubiński, J., & Gardovskis, J. (2025) · BMC Cancer · doi:10.1186/s12885-025-15110-y
Alteration in estrogen receptor status in metachronous contralateral breast cancer among unilateral early breast cancer patients with BRCA 1/2 mutations
Kim, K. J., Kang, E. K., Baek, S. H., Lee, H., Ahn, S. G., Park, W. K., Shin, D. S., Lee, H., Nam, S. J., Kim, S. W., et al. (2025) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2025.111332
High-risk screening using breast MRI
Price, J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139084833.007
Additional file 1 of A genome-wide association study of contralateral breast cancer in the Women’s Environmental Cancer and Radiation Epidemiology Study
Sun, X., Reiner, A. S., Tran, A. P., Watt, G. P., Oh, J. H., Mellemkjær, L., Lynch, C. F., Knight, J. A., John, E. M., Malone, K. E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25052223
Self-citation
Additional file 2 of A genome-wide association study of contralateral breast cancer in the Women’s Environmental Cancer and Radiation Epidemiology Study
Sun, X., Reiner, A. S., Tran, A. P., Watt, G. P., Oh, J. H., Mellemkjær, L., Lynch, C. F., Knight, J. A., John, E. M., Malone, K. E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25052524
Self-citation
Additional file 1 of Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study
Cheng, H.-F., Tsai, Y.-F., Liu, C.-Y., Hsu, C.-Y., Lien, P.-J., Lin, Y.-S., Chao, T.-C., Lai, J.-I., Feng, C.-J., Chen, Y.-J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654218
Does bilateral mastectomy affect clinical outcomes in BRCA1/2 mutation carriers with primary breast cancer? A systematic review and meta-analysis
Wagner, P. H. D. S., Matheus, G. T. F. U., Kamitani, H. Z., de Carvalho, P. L. A., & de Moraes, F. C. A. (2026) · Familial Cancer · doi:10.1007/s10689-026-00535-6
Integrating Genomic and Nongenomic Data to Stratify the Risk of Contralateral Breast Cancer After Radiation Therapy
Lee, S., Shu, X., Derkach, A., Reiner, A. S., Liang, X., Woods, M., CONCANNON, P. J., Lynch, C. F., Malone, K. E., Knight, J. A., et al. (2026) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2026.02.237
Self-citation
Prédispositions génétiques au cancer du sein et de l'ovaire dans la population suisse entre 1996 et 2009 : bilan de l'activité oncogénétique et du dépistage de mutations constitutionnelles dans les gènes BRCA1/BRCA2
Ayme, A. (2013) · theses.fr (ABES) · doi:10.70675/9e63b493z9591z4b85zb3d5zb41ad5fbfe7a
Contributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11)
Shin, S.-H., Ahn, S. G., Ryu, J. M., Lee, S. B., Park, H. S., Lee, E.-S., Lee, J., Kang, B., Kim, S., Kim, E. Y., et al. (2026) · Breast Cancer Research · doi:10.1186/s13058-026-02273-0
Multi-modal machine learning for breast cancer recurrence prediction
Shao, J., Wang, X., Khan, A. N., Brett, C. L., Li, X., & Yao, B. (2026) · IISE Transactions on Healthcare Systems Engineering · doi:10.1080/24725579.2026.2701461

Authors: Malone, K. E., Begg, C. B., Haile, R. W., Borg, A., Concannon, P., Tellhed, L., Xue, S., Teraoka, S., Bernstein, L., Capanu, M., Reiner, A. S., Riedel, E. R., Thomas, D. C., Mellemkjær, L., Lynch, C. F., Boice, J. D., Anton-Culver, H., & Bernstein, J. L.
Affiliations: University of Southern California (US)
From the Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Preventive Medicine, University of Southern California, Los Angeles; Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute, City of Hope, Duarte; Department of Epidemiology, University of California at Irvine, Irvine, CA; Department of Oncology, Lund...
ORCID: Malone, Kathleen E.
Begg, Colin B.
Haile, Robert W.
Concannon, Patrick
Xue, Shanyan
Bernstein, Leslie
Capanu, Marinela
Reiner, Anne S.
Thomas, Duncan C.
Mellemkjær, Lene
Lynch, Charles F.
Boice, John D.
Bernstein, Jonine L.
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2010-05-10
Volume: 28
Issue: 14
Pages: 2404-2410
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2009.24.2495
PMC: PMC2881721
OpenAlex: W2107243201
Cited by: 191
References: 36
Citations by year: 2026: 5 · 2025: 8 · 2024: 12 · 2023: 9 · 2022: 4 · 2021: 5 · 2020: 18 · 2019: 5 · 2018: 10 · 2017: 14 · 2016: 19 · 2015: 16 · 2014: 11 · 2013: 17 · 2012: 20
FWCI: 9.88
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Oncology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Lund University Publications (Lund University) (submittedVersion)
Funders: National Institute on Aging (R01AG014358)
National Cancer Institute (R01CA097397, U01CA083178, R01CA131010, R01CA129639)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Health Sciences › Medicine › Epidemiology › Multiple and Secondary Primary Cancers
Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
Keywords: contralateral breast cancer, BRCA1 mutation, BRCA2 mutation, hereditary breast cancer, second primary cancer risk, cumulative risk, age at first diagnosis, mutation carriers, genetic counseling, early-onset breast cancer
MeSH terms: Adult, Age Factors, Breast Neoplasms, Denmark, DNA Mutational Analysis, Female, Humans, Middle Aged, Mutation, Neoplasm Recurrence, Local, Population Surveillance, Risk Factors, Time Factors, United States, Logistic Models, Case-Control Studies, Treatment Outcome, SEER Program, Risk Assessment, BRCA1 Protein, Genetic Predisposition to Disease, BRCA2 Protein, Apoptosis Regulatory Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks